Tag Archives: Barriers to Innovation: Dominance of Vested Interests

Fair and Affordable Access to Medicines in the NHS (NHS England / UCL IIPP)

Posted on October 19, 2018 by Dementia and Elderly Care News

Summary Adalimumab is a medicine on which hospitals spend more than £400 million a year. The patent has now expired, allowing patients to be treated with a cheaper biosimilar, saving around £150 million per year (which can be re-directed to … Continue reading →

Posted in Acute Hospitals, Commissioning, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, National, NHS, NHS England, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Access to Medicines, Adalimumab, Added Benefit of New Drugs (Analysis), Affordability, Affordability (Facilitators of Innovation), Affordability and Access to Essential Medicines, Affordable Medicines, Alignment of Corporate Interests With the Public Interest, Alternative Health Innovation Model (Proposals), Andrew Davies: Director of Hospital Pharmacy at NHS Improvement, Association of the British Pharmaceutical Industry (ABPI), Barriers to Collaboration and Knowledge Sharing, Barriers to Innovation, Barriers to Innovation: Dominance of Vested Interests, Better Procurement, BioCubaFarma, Biological Medicines and Biosimilars, Biosimilars for Adalimumab, Cancer Innovation Fund (CIF), Charging Prices the Market Will Bear, Collaboration and Transparency, Compulsory Licensing, Compulsory or Public Non-Commercial Use Licences, Decline of Drugs Research and Development Efficiency, Defense Advanced Research Projects Agency (Darpa), Delinkage, Delinkage of Incentives for Innovation From High Prices, Directed Innovation, Direction of Innovation for Public Value, Drug Patent Monopolies: Negation of Competition, Drug Patents, Drug Pricing Negotiations, Drug Pricing Strategies, Drugs for Neglected Diseases initiative (DNDi), Effective Knowledge Sharing, Energiewende in Germany, European Public Health Alliance, Expensive Drugs, Finance and Budgeting: Affordability (Barriers to Innovation), Finance and Procurement, Global Justice Now, Health Advanced Research Projects Agency (HARPA), Health Innovation, Health Innovation Better Managed to Deliver Public Value, Heidi Chow: Global Justice Now, High Medication Prices Placing Pressure on NHS Budgets and Causing Rationing, High Prices Failing to Reflect Social Value, Highly-Priced Medicines, Human Genome Project (HGP), I-MAK, Improving Access to Medicines, Incentivising Investment in Innovation, Inefficiencies in Innovation, Innogen, Innovation and Improvement, Innovation Direction, Intellectual Property Rights (IPR) Geared to Encouraging Innovation, Intellectual Property Rights (IPR) Geared to Public Value, Intellectual Property Rules Geared for Public Health, International Nonproprietary Names (INN), Just Treatment, Knowledge Ecology International, Knowledge Governance, Lack of Safeguards in Current Pharma R&D Model, Lack of Transparency and Public Accountability, Lack of Transparency and Stifled Collaboration, Learning from DARPA, Mariana Mazzucato: UCL Institute for Innovation and Public Purpose, Me-Too Drugs, Medicines Patent Pool (MPP), Medicines Price Transparency, Mission-Driven Innovation, Mission-Oriented Innovation Policy, Mission-Oriented Thinking, Monopoly Pricing, Open Society Foundations, Opportunities for Volume-Based and Pooled Procurement, Out-of-Reach Drug Prices, Patent Monopolies Negating Competition, Patentability Criteria Consistent With TRIPS Agreement, Patents Blocking Learning Diffusion and Collaboration, People’s Prescription: Re-Imagining Health Innovation to Deliver Public Value, Pharmaceutical Price Regulation Scheme (PPRS), Pooled Procurement Mechanism, Pricing Legislation, Principles of Health Innovation Model Designed For Public Value, Procurement, Profit Maximisation Versus Public Value Maximisation, Public Investment in Biomedical Innovation, Public Purpose, Public Purpose and Public Value, Public Value, Public Value Maximisation, Reducing Spending on Expensive Drugs, Reducing Waste in the NHS, Saoirse Fitzpatrick: STOPAIDS, Short-Termism and Financialisation, Simon Stevens: Chief Executive of NHS England, Smart Procurement, Social Value, STOPAIDS, Thinking Like a Patient and Acting Like a Taxpayer, Trade Related Aspects of Intellectual Property Rights (TRIPS), TRIPS Agreement, TRIPs-Plus Provisions, Upstream Investment in Research and Development Negotiated Into Better Downstream Public Benefit, US Biochemical Advanced Research and Development Authority (BARDA), US Department of Health: Health Advanced Research Projects Agency (HARPA), Value Based Pricing, Value-Based Pricing (Imperfect Model), Value-Based Pricing: Corrupted Into Maximising Value Extraction (Versus Public Good), Variations in Procurement, Voluntary Scheme for Branded Medicines Pricing and Access, World Intellectual Property Organisation (WIPO) | Leave a comment

An Innovative Approach Hospital Overcrowding / Inadequate Bed Availability, Worthy of More Serious Consideration? (BBC News / CareRooms)

Posted on October 28, 2017 by Dementia and Elderly Care News

Summary The narrative about various inter-related crises in health and social care typically concerns the problem of excess demand for, and limited supply of, places in the community providing support for persons needing to be discharged from hospitals. Commentators commonly … Continue reading →

Posted in Acute Hospitals, BBC News, Commissioning, Community Care, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Housing, In the News, Integrated Care, Management of Condition, National, NHS, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, Standards, UK, Universal Interest | Tagged Acute Hospital Care, Adult Social Care, Adult Social Care Services, Ageing Population, Airbnb Beds Plan (Proposed), Alternative Residential Care Settings, Alternatives to Hospital Care, Barriers and Challenges in Discharge Planning, Barriers in Access to Transformative Care in the Community: Dominance of Residential Care Homes Paradigm, Barriers to Innovation, Barriers to Innovation: Dominance of Mainstream Preconceptions, Barriers to Innovation: Dominance of Vested Interests, Barriers to Innovation: Vested Interests in Opposition to New Market Entries, Barriers to Joined-Up Care, Barriers to Support, Barriers: Lack of Continuity of Care, BBC Essex, BBC Health News, Bed Availability and Occupancy, Bed Days, Bed Shortages, Bed-Blockers, Bed-Blocking Patients (Non-Recommended Term), Care Closer to Home, Care for Vulnerable Older People, Care Home Admission Delay, Care of Older People, CareRooms, Cross-Sector Partnerships, Delayed Discharges, Delayed Discharges Higher in Mental Health Trusts, Delayed Transfers of Care, Delayed Transfers of Care (DTOC), Demand and Capacity, Disruptive Innovation, Dr Harry Thirkettle: CareRooms, Economic Sustainability, Efficiency Opportunities, Fewer Older People Receiving Help with Social Care, Financial Incentives Across Local Health and Social Care Systems (Proposals), Financial Sustainability in the NHS, Fragility of Adult Social Care Provider Market, Funding Deficits, Funding for Front-Line Healthcare Versus Social Care, Future of Residential Care, Health and Adult Social Care Providers, Health and Care of Older People, Health and Care Suitable for an Ageing Population, Health and Social Care, Health and Social Care in the Community, Health and Social Care Integration, Health Demand, Hospital Beds, Hospital Overcrowding, Inadequate Bed Availability, Innovation for an Ageing Population, Innovative Disruption (To a Failing Market), Loneliness and Isolation, Loss of Mobility During Long Hospital Stays, Market Failure, Market Failure in Social Care, NHS Airbnb-Style Scheme, NHS Sustainability, Operations Cancelled Due to Bed Shortages, Overcoming Barriers, Patient Discharge, Patient Flows, Patient Handover Delays, Patient Safety, Philip Dunne: Minister of State for Health, Physical Therapy, Physiotherapists, Physiotherapy, Poor Identification of People’s Capacity For Involvement in Their Care Planning and Management (Barriers to Involvement), Post-Discharge Support, Preventing Loneliness, Prevention of Avoidable Emergency Admissions: Team-Based Interventions in A&E, Proportionality in Safeguarding, Quality and Sustainability, Reablement, Reablement Services, Reducing Bed Days, Reducing Inappropriate Accident and Emergency Department Attendances, Reducing Over-Reliance on Social Care, Reducing Pressure on Primary Care, Reducing Waste in the NHS, Safeguarding, Safeguarding Adults at Risk, Social Isolation and Loneliness, Southend University Hospital NHS Foundation Trust, Sustainability, Sustainable Health and Social Care, Thinking Like a Patient and Acting Like a Taxpayer, Tom Abell: Deputy Chief Executive at Southend University Hospital NHS Foundation Trust, Under-Utilisation of Housing Stock, Vested Interests, Vulnerable Older People, Wasted Resources, Whole System Patient Flows | Leave a comment

Tag Archives: Barriers to Innovation: Dominance of Vested Interests

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites